Royce & Associates »

Kymera Therapeutics shares owned by Royce & Associates

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Royce & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $285k 7.1k 40.20
2023-12-31 $408k 16k 25.46